PDB43 PATIENT REPORTED OUTCOMES ARE SUPERIOR IN PATIENTS WITH TYPE 2 DIABETES TREATED WITH LIRAGLUTIDE AS COMPARED TO EXENATIDE, WHEN ADDED TO METFORMIN, SULFONYLUREA OR BOTH
May 1, 2009, 00:00
10.1016/S1098-3015(10)73586-5
https://www.valueinhealthjournal.com/article/S1098-3015(10)73586-5/fulltext
Title :
PDB43 PATIENT REPORTED OUTCOMES ARE SUPERIOR IN PATIENTS WITH TYPE 2 DIABETES TREATED WITH LIRAGLUTIDE AS COMPARED TO EXENATIDE, WHEN ADDED TO METFORMIN, SULFONYLUREA OR BOTH
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)73586-5&doi=10.1016/S1098-3015(10)73586-5
First page :
Section Title :
Open access? :
No
Section Order :
38